Lutz Ulrich Jochen Jermutus

Title: Lutz Ulrich Jochen Jermutus: Innovator in Human Antibody Molecules

Introduction

Lutz Ulrich Jochen Jermutus is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of human antibody molecules. His work focuses on addressing various IL-13 related disorders, showcasing his commitment to advancing medical science.

Latest Patents

Jermutus holds a patent for "Human antibody molecules for IL-13." This patent includes specific binding members, particularly human anti-IL-13 antibody molecules that neutralize IL-13 activity. The methods outlined in his patent are aimed at using these anti-IL-13 antibody molecules in the diagnosis or treatment of disorders such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease, and Hodgkin's lymphoma. He has 1 patent to his name.

Career Highlights

Lutz Ulrich Jochen Jermutus is associated with MedImmune Limited, a company known for its innovative approaches in the biopharmaceutical sector. His work at MedImmune has allowed him to contribute to groundbreaking research and development in antibody therapies.

Collaborations

Throughout his career, Jermutus has collaborated with notable professionals in the field, including Ralph Raymond Minter and Phillip David Monk. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Lutz Ulrich Jochen Jermutus is a key figure in the development of human antibody therapies, with a focus on IL-13 related disorders. His contributions to the field of biotechnology continue to pave the way for advancements in medical treatments.